Trial
NCT04614467
A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Lisata Therapeutics, Inc.
Collaborators
—
Condition
Coronary Microvascular Dysfunction
Intervention
CLBS16
Why stopped
Sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-04